Exploring the intricate landscape of cardiac lipidomics, this dynamic field delves into the intricate world of lipid molecules within the cardiovascular system. As crucial components of cell membranes, lipids play an essential role in shaping cellular structure and functionality. In the realm of cardiac health, lipidomics extends its reach to comprehensively study the lipid composition of cardiac tissues, shedding light on their multifaceted roles in both physiological equilibrium and pathological disruptions. By unraveling the complexities of the heart's lipidomic profile, researchers gain valuable insights into lipid metabolism, signaling pathways, and their implications for various cardiac conditions, ranging from atherosclerosis to heart failure. Utilizing cutting-edge analytical techniques, experts in cardiac lipidomics strive to characterize diverse lipid species, opening avenues for innovative diagnostic tools and therapeutic interventions to tackle cardiovascular disorders. This fusion of lipid biochemistry and cardiology not only offers a deeper understanding of cardiac lipidomics but also holds the potential to uncover novel biomarkers and therapeutic targets, fostering advancements in cardiovascular medicine.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt